458
Views
0
CrossRef citations to date
0
Altmetric
Review

Exploring the measurement of pediatric cognitive-communication disorders in traumatic brain injury research: A scoping review

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1207-1227 | Received 29 Aug 2021, Accepted 03 Aug 2022, Published online: 27 Oct 2022
 

ABSTRACT

Objective

To synthesize information about the constructs measured, measurement instruments used, and the timing of assessment of cognitive-communication disorders (CCDs) in pediatric traumatic brain injury (TBI) research.

Methods and Procedures

Scoping review conducted in alignment with Arksey and O’Malley’s five-stage methodological framework and reported per the PRISMA extension for Scoping Reviews. Inclusion criteria: (a) cohort description, case–control, and treatment studies; (b) participants with TBI aged 5–18 years; (c) communication or psychosocial outcomes; and (d) English full-text journal articles. The first author reviewed all titles, abstracts, and full-text articles; 10% were independently reviewed.

Outcomes and Results

Following screening, a total of 687 articles were included and 919 measurement instruments, measuring 2134 unique constructs, were extracted. The Child Behavior Checklist was the most used measurement instrument and ‘Global Outcomes/Recovery’ was the construct most frequently measured. The length of longitudinal monitoring ranged between ≤3 months and 16 years.

Conclusions and Implications

We found considerable heterogeneity in the constructs measured, the measurement instruments used, and the timing of CCD assessment in pediatric TBI research. A consistent approach to measurement may support clinical decision-making and the efficient use of data beyond individual studies in systematic reviews and meta-analyses.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Supplementary material

Supplemental data for this article can be accessed online at https://doi.org/10.1080/02699052.2022.2111026

Additional information

Funding

Sarah Wallace is supported by a National Health and Medical Research Council (NHMRC) Emerging Leadership Investigator Grant (APP1175821).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.